Maxair

   
Google
 
Web NewDrugInformation.com

Maxair


Drug - Maxair
The trade name of the product as shown on the labeling.

Dosage - AEROSOL, METERED; INHALATION
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Pirbuterol Acetate
Multiple ingredients are in alphabetical order.

Strength - EQ 0.2MG BASE/INH
The potency of the active ingredient(s), Pirbuterol Acetate. May repeat for multiple part products.

Applicant - 3M
The firm name holding legal responsibility for Maxair. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 019009
The FDA assigned number to Maxair. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Maxair. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Dec 30, 1986
The date Maxair was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Maxair. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - DISCN
The group or category of approved drugs Maxair is in. Format is RX, OTC, DISCN.

Applicant Full Name - 3m Pharmaceuticals Inc
The full name of the firm holding legal responsibility for the new application of Maxair.

Maxair